Genprex, Inc.
NASDAQ Capital MarketTotal Valuation
Genprex, Inc. carries a market capitalization of 1.08M, placing it among publicly traded companies globally.
| Market Cap | 1.08M |
| Enterprise Value | N/A |
Share Statistics
Genprex, Inc. currently has 504,935.00 shares outstanding.
| Shares Outstanding | 504,935.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | -0.20 |
| P/OCF Ratio | -0.20 |
Financial Position
Genprex, Inc. maintains a current ratio of 6.77, meaning it holds 6.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.77 |
| Quick Ratio | 6.47 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -21.41 |
Financial Efficiency
| Return on Equity (ROE) | -203.86 |
| Return on Assets (ROA) | -157.40 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Genprex, Inc.'s stock has declined approximately -99.30844% over the past 52 weeks. The 50-day moving average sits at 3.39, while the 200-day moving average is 22.48.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.30844% |
| 50-Day Moving Average | 3.39 |
| 200-Day Moving Average | 22.48 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -15.84M, while operating income came in at -15.84M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -15.84M |
| Pretax Income | -16.50M |
| Net Income | -16.50M |
| EBITDA | -15.84M |
| EBIT | -15.84M |
| Earnings Per Share (EPS) | -60.09 |
Balance Sheet
Total book value stands at 14.80M, with working capital of 13.50M providing operational flexibility.
| Cash & Cash Equivalents | 15.15M |
| Total Debt | N/A |
| Net Debt | -15.15M |
| Equity (Book Value) | 14.80M |
| Book Value Per Share | 29.30 |
| Working Capital | 13.50M |
Cash Flow
Genprex, Inc. produced -15.56M in operating cash flow over the past twelve months.
| Operating Cash Flow | -15.56M |
| Capital Expenditures | N/A |
| Free Cash Flow | -15.56M |
| FCF Per Share | -56.68 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -509.33 |
| FCF Yield | -496.31 |
Stock Splits
Genprex, Inc.'s most recent stock split took place on July 16, 2026 with a 22:1 split ratio.
| Last Split Date | 7/16/2026 |
| Split Ratio | 22:1 |
Scores
Genprex, Inc. posts an Altman Z-Score of -15.33, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -15.33 |